Celsius Holdings, Inc. (NASDAQ:CELH) HOLD
Genuine thesis damage, not a tape wobble. Q2 missed for the first time in five quarters and the flagship Celsius brand fell about 12 percent, so Business Quality drops High to Medium and the medium- and long-term BUYs are withdrawn. All three horizons are now HOLD - cheaper near 15 times forward earnings, but a value-trap risk until the core brand turns.
Celsius Holdings is a functional-beverage company - the clear US number two in energy drinks, behind Monster and Red Bull, with the flagship CELSIUS line plus the acquired Alani Nu and Rockstar brands, sold through PepsiCo's distribution network. It runs an asset-light model with high margins and strong cash conversion. The report rates it a hold across all three horizons - a downgrade from buy - at a price of $23.77 after a 19 percent post-earnings drop.
The core engine turned negative
Start with what actually changed, because it is a quality problem, not a price wobble. Total second-quarter revenue still grew about 11 percent to $817.9 million, but that growth is now carried by acquisitions - Alani Nu was up 56 percent - while the flagship Celsius brand fell roughly 12 percent year on year. That was the first revenue miss in five quarters, about $55 million light of consensus. Gross margin compressed from 51.5 to 48.1 percent and operating income halved. Because the organic core has turned negative, Business Quality drops from High to Medium and the medium and long calls come off BUY.
Cheaper - but a value-trap risk
Here is the tension in the call. After a 19 percent drop the stock trades near 15 times forward earnings with an 8.7 percent free-cash-flow yield, and the warranted multiple works out around 17.8 times - so on the numbers it screens attractive. But cheap is not the same as a buy. The probability-weighted fair value is about $27, essentially where the stock already sits, so there is no valuation gap to close until the flagship brand stabilises. Ignore the headline talk of about 100 percent upside to analyst targets - those targets predate the crash and are being cut. This is why Valuation holds a 65 but the signal is still hold.
Don't catch the knife
The tape is the third reason to wait. Timing scores just 36 - every higher timeframe is in a downtrend, the daily is in a strong downtrend below both the 50- and 200-day, and the miss produced a capitulation flush of 19 percent on 4.4 times average volume to a 16-month low. Daily RSI near 31 is oversold and the 15-minute is trying to recover, which hints at a relief bounce, but there is no confirmed reversal and no reclaim of the roughly $29.6 fifty-day. The Technical entry group is unmet, so the short call stays hold - a tested higher-low, or Q3 evidence the core has stabilised, would materially improve the entry.
What could go wrong
Core Celsius brand shrinking (−12%) - the thesis damage. HIGH competition: Monster, Red Bull, KDP-Ghost, Kirkland. Poppi/Olipop prebiotics + GLP-1 steal 'health' occasions. Legal overhang: Texas-AG caffeine probe + Pomerantz suit. Estimates not done being cut; analyst targets are stale. Acquisition dilution +9% YoY share count.
Risk vs Reward
Against the current US$23.77, the report frames a bull case at US$36 (+51%), a base case at US$27 (+14%) and a bear case at US$18 (-24%). See the full report for the probability weight behind each path.
The verdict
Genuine thesis damage, not a tape wobble. Q2 missed for the first time in five quarters and the flagship Celsius brand fell about 12 percent, so Business Quality drops High to Medium and the medium- and long-term BUYs are withdrawn. All three horizons are now HOLD - cheaper near 15 times forward earnings, but a value-trap risk until the core brand turns.
Read the full report on donatien.ca →
